Masimo | MASI - Sales Revenues

Masimo reported $548.9M in Sales Revenues for its fiscal quarter ending in December of 2023.

Sales Change Date
Abbott USD 9.96B 281M Mar/2024
Align Technology USD 997.4M 40.67M Mar/2024
AtriCure USD 106.54M 8.25M Dec/2023
Avanos Medical USD 173.3M 2M Dec/2023
Baxter International USD 3.88B 177M Dec/2023
Becton, Dickinson and Co. USD 4.71B 381M Dec/2023
Boston Scientific USD 3.86B 135M Mar/2024
Dexcom USD 921M 113.5M Mar/2024
Edwards Lifesciences USD 1.6B 65.9M Mar/2024
General Electric USD 16.1B 3.32B Mar/2024
Globus Medical USD 616.53M 232.9M Dec/2023
Haemonetics USD 336.25M 18.07M Dec/2023
Insulet USD 509.8M 77.1M Dec/2023
Integra LifeSciences USD 397.04M 14.62M Dec/2023
Intuitive Surgical USD 1.89B 38.3M Mar/2024
Masimo USD 548.9M 70M Dec/2023
Medtronic USD 8.09B 105M Dec/2023
Owens Minor USD 2.66B 64.41M Dec/2023
ResMed USD 1.2B 37.2M Mar/2024
Steris USD 1.4B 53.28M Dec/2023
Stryker USD 5.82B 906M Dec/2023
Tandem Diabetes Care USD 196.8M 11.17M Dec/2023
Teleflex USD 773.91M 27.52M Dec/2023
Thermo Fisher Scientific USD 10.34B 546M Mar/2024
Zimmer Biomet Holdings USD 1.94B 186.5M Dec/2023